For the purposes of this Chapter, a drug shall be deemed to be spurious,-
(a) if it is manufactured under a name which belongs to another drug; or
(b) if it is an imitation of, or is a substitute for, another drug or resembles another drug in a manner likely to deceive or bears upon it or upon its label or container the name of another drug unless it is plainly and conspicuously marked so as to reveal its true character and its lack of identity with such other drug; or
(c) if the label or container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist; or
(d) if it has been substituted wholly or in part by another drug or substance; or
(e) if it purports to be the product of a manufacturer of whom it is not truly a product.
Section 16 Standards of quality
Section 17C Misbranded cosmetics
Section 17D Spurious cosmetics
Section 17E Adulterated cosmetics
Section 18 Prohibition of manufacture and sale of certain drugs and cosmetics
Section 18A Disclosure of the name of the manufacturer, etc
Section 18B Maintenance of records and furnishing of information
Section 20 Government Analysts
Section 22 Powers of Inspectors
Section 23 Procedure of Inspectors
Section 24 Persons bound to disclose place where drugs or cosmetics are manufactured or kept
Section 25 Reports of Government Analysts
Section 26 Purchaser of drug or cosmetic enabled to obtain test or analysis
Section 27 Penalty for manufacture, sale, etc., of drugs in contravention of this Chapter
Section 27A Penalty for manufacture, sale, etc., of cosmetics in contravention of this Chapter
Section 28 Penalty for non-disclosure of the name of the manufacturer, etc
Section 28A Penalty for not keeping documents, etc., and for non-disclosure of information
Section 28B Penalty for manufacture, etc., of drugs or cosmetics in contravention of section 26A
Section 29 Penalty for use of Government Analyst's report for advertising